In 2003, the generics manufacturer Apotex filed an application to the FDA to market amlodipine besylate, the active ingredient in Norvasc, claiming that the Pfizer patent (US 4,879,303), which ...

Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

The US Court of Appeals for the Federal Circuit has reversed the New Jersey District Court's dismissal of Pfizer's patent infringement action against Dr Reddy's Laboratories' generic version of ...

Amlodipine, commonly known as Norvasc, is a calcium channel blocker medication that is approved by the Food and Drug Administration (FDA) to treat high blood pressure, chest pain, and coronary ...

Amlodipine (brand name Norvasc) and lisinopril (brand name Zestril) are widely prescribed medications for lowering blood ...